Bering Strait Theory, Pt. 6: DNA, Blood Types and Stereotypes
By Alex Ewen,
Indian Country Today Media Network
| 07. 19. 2014
Untitled Document
Archaeological discoveries in South America in the 1980s led to a revision in the timeline of the Bering Strait Theory, throwing the whole theory into doubt. But the dogmatic insistence on a single passageway in a certain time period was also being challenged on many other fronts.
It is generally presumed that the new science of genetics is providing support for the Bering Strait Theory, but that is not necessarily so. The idea that we are all related is a concept well known among American Indians and therefore the fact that new genetic studies are detailing these relationships among humans is not surprising. The question is not so much, “are there relationships?” but do these the new details actually shed light on the movements of populations in the past.
Adding to the confusion surrounding genetic studies is the newness of the science, which has caused genetics to be heavily influenced by the archaeologists, and thus already predisposed to the Bering Strait Theory. More unfortunate has been the use by geneticists of the pseudo-scientific classifications of American Indians proposed...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...